Speaker(s): 

Sreelatha Naik, MD, Staff Member, Geisinger, is a Consultant/Advisor for ResMed.

Moderator(s): 

Anil Singh, MD, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Evaluate guideline-based and phenotype-targeted strategies for chronic COPD management.

  • Integrate evidence-based interventions into the in-patient care of COPD exacerbations.

  • Appraise the role of chronic noninvasive ventilation in hypercarbic respiratory failure in COPD

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anil Kumar Singh, MD, Roop Parlapalli, MD, FHM, FACP, Lakshmi Rani Gollamudi, MD, Christopher DeFrancesco PharmD, RPH, Mary Ellen Berry, PA-C, and Carlena Miller, CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 
Katie Klinger, MEd and April Morgan, EdD
 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
08/08/2025 - 12:00pm to 1:00pm EDT
Location: 
Geisinger Community Medical Center
1800 Mulberry Street
Scranton 18510
United States
  • 1.00 AAPA Category I CME
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.